At a glance
- Originator Abbott Japan
- Class Antiallergics; Antiasthmatics; Antihistamines; Benzoxepins; Pyridines; Small molecules
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic rhinitis; Urticaria
Most Recent Events
- 15 Feb 2008 Discontinued - Phase-II for Allergic rhinitis in Japan (PO)
- 15 Feb 2008 Discontinued - Phase-II for Urticaria in Japan (PO)
- 23 Sep 2004 No development reported - Phase-II for Allergic rhinitis in Japan (PO)